Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / 항체 의존성 세포 독성 변형 화합물의 식별을 위한 High-content…
JoVE Journal
Cancer Research
Author Produced

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Cancer Research
항체 의존성 세포 독성 변형 화합물의 식별을 위한 High-content screening assay
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Journal (Cancer Research)
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
Journal (Cancer Research)
Production of High-Titer Recombinant Newcastle Disease Virus from Allantoic Fluid
 
Click here for the English version

항체 의존성 세포 독성 변형 화합물의 식별을 위한 High-content screening assay

Article DOI: 10.3791/64485-v • 13:59 min • August 18th, 2023
August 18th, 2023 •
*1,2, *1,3, *1,3, 1, 1,4, 1,4
1Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, 2Doctoral School of Molecular Medicine, University of Debrecen, 3National Academy of Scientist Education, University of Debrecen, 4ELKH-DE Cell Biology and Signaling Research Group
* These authors contributed equally

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

이 프로토콜은 치료용 항-HER-2 항체가 있는 상태에서 자연 살해 세포 매개 유방암 세포 사멸을 조절하는 화합물을 식별하기 위한 자동화된 이미지 기반 고처리량 기술을 제시합니다.

Tags

이번 달 JoVE
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter